Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer

[1]  Stephen T. C. Wong,et al.  Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling , 2014, Proceedings of the National Academy of Sciences.

[2]  Y. Suh,et al.  Fractionated radiation‐induced nitric oxide promotes expansion of glioma stem‐like cells , 2013, Cancer science.

[3]  H. Kishimoto,et al.  Effect of a nitric oxide synthase inhibitor and a CXC chemokine receptor-4 antagonist on tumor growth and metastasis in a xenotransplanted mouse model of adenoid cystic carcinoma of the oral floor. , 2013, International journal of oncology.

[4]  J. Weiss,et al.  TGF-β signaling in myeloid cells is required for tumor metastasis. , 2013, Cancer discovery.

[5]  G. Chaudhuri,et al.  Mitochondrial-associated nitric oxide synthase activity inhibits cytochrome c oxidase: implications for breast cancer. , 2013, Free radical biology & medicine.

[6]  S. Glynn,et al.  The yin and yang of nitric oxide in cancer progression. , 2013, Carcinogenesis.

[7]  Ian Krop,et al.  Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors , 2013, Clinical Cancer Research.

[8]  J. Bussink,et al.  Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response , 2013, Breast Cancer Research.

[9]  Rajdeep Chowdhury,et al.  Nitric oxide produced endogenously is responsible for hypoxia-induced HIF-1α stabilization in colon carcinoma cells. , 2012, Chemical research in toxicology.

[10]  S. Ambs,et al.  Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer , 2012, Breast Cancer Research.

[11]  J. Nyman,et al.  Transforming Growth Factor β Suppresses Osteoblast Differentiation via the Vimentin Activating Transcription Factor 4 (ATF4) Axis* , 2012, The Journal of Biological Chemistry.

[12]  C. Blanpain,et al.  Defining the mode of tumour growth by clonal analysis , 2012, Nature.

[13]  E. Brimble,et al.  TDAG51 mediates epithelial-to-mesenchymal transition in human proximal tubular epithelium. , 2012, American journal of physiology. Renal physiology.

[14]  I. Voutsadakis.  The ubiquitin–proteasome system and signal transduction pathways regulating Epithelial Mesenchymal transition of cancer , 2012, Journal of Biomedical Science.

[15]  S. Fischer,et al.  Untargeted Plasma Metabolite Profiling Reveals the Broad Systemic Consequences of Xanthine Oxidoreductase Inactivation in Mice , 2012, PloS one.

[16]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[17]  S. Babykutty,et al.  Insidious role of nitric oxide in migration/invasion of colon cancer cells by upregulating MMP-2/9 via activation of cGMP-PKG-ERK signaling pathways , 2012, Clinical & Experimental Metastasis.

[18]  Jenny C. Chang,et al.  Epithelial-mesenchymal transition, cancer stem cells and treatment resistance , 2012, Breast Cancer Research.

[19]  D. Ann,et al.  Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein. , 2011, American journal of respiratory cell and molecular biology.

[20]  T. Blackwell,et al.  Alveolar Epithelial Cells Undergo Epithelial-to-Mesenchymal Transition in Response to Endoplasmic Reticulum Stress* , 2011, The Journal of Biological Chemistry.

[21]  J. Stamler,et al.  Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2 , 2011, Cell.

[22]  R. Stephens,et al.  Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. , 2010, The Journal of clinical investigation.

[23]  Stephen A. Ramsey,et al.  ATF3, an adaptive-response gene, enhances TGFβ signaling and cancer-initiating cell features in breast cancer cells , 2010, Journal of Cell Science.

[24]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[25]  Jeffrey M. Rosen,et al.  Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.

[26]  T. Sanke,et al.  Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis , 2008, BMC Cancer.

[27]  Kou-Juey Wu,et al.  TWIST activation by hypoxia inducible factor-1 (HIF-1): Implications in metastasis and development , 2008, Cell cycle.

[28]  F. Beguinot,et al.  ER stress is associated with dedifferentiation and an epithelial-to-mesenchymal transition-like phenotype in PC Cl3 thyroid cells , 2008, Journal of Cell Science.

[29]  F. Van de Werf,et al.  Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. , 2007, JAMA.

[30]  T. Barrette,et al.  Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. , 2007, Neoplasia.

[31]  S. Sak,et al.  Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases , 2005, Virchows Archiv.

[32]  Syed Mohsin,et al.  Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  G. Pignataro,et al.  HIF‐1α reveals a binding activity to the promoter of iNOS gene after permanent middle cerebral artery occlusion , 2004 .

[34]  Z. Radisavljevic.  Inactivated tumor suppressor Rb by nitric oxide promotes mitosis in human breast cancer cells , 2004, Journal of cellular biochemistry.

[35]  J. Bakker,et al.  Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock* , 2004, Critical care medicine.

[36]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[37]  C. Denkert,et al.  Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumour cell invasion , 2002, British Journal of Cancer.

[38]  B. Telfer,et al.  17β-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on growth and radiation response , 2002, British Journal of Cancer.

[39]  L. Magnelli,et al.  Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions , 2001, The Journal of pathology.

[40]  Y. Soini,et al.  Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[41]  P. Lala,et al.  Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis , 2000, International journal of cancer.

[42]  K. Rg,et al.  Strategies to reduce side effects of interleukin-2: evaluation of the antihypotensive agent NG-monomethyl-L-arginine. , 2000 .

[43]  C. Harris,et al.  Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. , 1998, Cancer research.

[44]  C. Szabó,et al.  BENEFICIAL VERSUS DETRIMENTAL EFFECTS OF NITRIC OXIDE SYNTHASE INHIBITORS IN CIRCULATORY SHOCK LESSONS LEARNED FROM EXPERIMENTAL AND CLINICAL STUDIES , 1997, Shock.

[45]  D. S. Lind,et al.  Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. , 1996, The Journal of surgical research.

[46]  Richard Graham Knowles,et al.  Nitric oxide synthase activity in human breast cancer. , 1995, British Journal of Cancer.

[47]  J. Weiss,et al.  NOS2 enhances KRAS‐induced lung carcinogenesis, inflammation and microRNA‐21 expression , 2013, International journal of cancer.

[48]  Tzong-Shiue Yu,et al.  A restricted cell population propagates glioblastoma growth after chemotherapy , 2012 .

[49]  Yuan-Xiang Pan,et al.  Activation of the ATF3 gene through a co-ordinated amino acid-sensing response programme that controls transcriptional regulation of responsive genes following amino acid limitation. , 2007, The Biochemical journal.

[50]  S. Loibl,et al.  The role of early expression of inducible nitric oxide synthase in human breast cancer. , 2005, European journal of cancer.

[51]  G. Pignataro,et al.  HIF-1alpha reveals a binding activity to the promoter of iNOS gene after permanent middle cerebral artery occlusion. , 2004, Journal of neurochemistry.

[52]  O. Griffith,et al.  Strategies to reduce side effects of interleukin-2: evaluation of the antihypotensive agent NG-monomethyl-L-arginine. , 2000, The cancer journal from Scientific American.